GSK vs MNKD · P/E 13, $103.31B cap vs rev $199.5M
GlaxoSmithKline PLC ADR (GSK) versus MannKind Corp (MNKD) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
MannKind Corp (MNKD) is a biotechnology company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported MNKD revenue for 2026-06-30 was $199.5M. Net income was -$35.7M. MNKD currently screens at market cap $1.28B.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. MNKD currently screens at market cap $1.28B.
Not investment advice. Open the GSK and MNKD stock pages for the full models.
Not investment advice.